Overview
Orofaciodigital syndrome type 3 (OFD3), also known as Sugarman syndrome, is an extremely rare genetic disorder characterized by abnormalities of the mouth (oral), face (facial), and fingers and toes (digital). This condition was first described by Sugarman and colleagues in 1971. Key clinical features include abnormalities of the teeth (such as supernumerary or malpositioned teeth), lobulated tongue or tongue hamartomas, cleft lip and/or palate, and digital anomalies including postaxial polydactyly and clinodactyly. Facial features may include a broad nasal root and other midface abnormalities. A distinguishing feature of OFD3 compared to other orofaciodigital syndromes is the association with significant intellectual disability and characteristic eye findings including myopia. Skeletal abnormalities may also be present. OFD3 affects multiple body systems including the craniofacial structures, the central nervous system, the skeletal system, and the eyes. The condition is apparent at birth or early infancy due to the visible oral, facial, and digital malformations. There is no specific cure or targeted therapy for OFD3. Management is supportive and symptomatic, typically involving a multidisciplinary team including oral and maxillofacial surgeons, orthopedic specialists, ophthalmologists, and developmental specialists. Surgical correction of cleft lip/palate, dental anomalies, and polydactyly may be performed as needed. Early intervention programs and educational support are important for addressing intellectual disability. Due to the extreme rarity of this condition, with only a handful of reported cases in the medical literature, knowledge about the full clinical spectrum and long-term prognosis remains limited.
Also known as:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Orofaciodigital syndrome type 3.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Orofaciodigital syndrome type 3 at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Orofaciodigital syndrome type 3.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Orofaciodigital syndrome type 3.
Community
No community posts yet. Be the first to share your experience with Orofaciodigital syndrome type 3.
Start the conversation →Latest news about Orofaciodigital syndrome type 3
No recent news articles for Orofaciodigital syndrome type 3.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Orofaciodigital syndrome type 3
What is Orofaciodigital syndrome type 3?
Orofaciodigital syndrome type 3 (OFD3), also known as Sugarman syndrome, is an extremely rare genetic disorder characterized by abnormalities of the mouth (oral), face (facial), and fingers and toes (digital). This condition was first described by Sugarman and colleagues in 1971. Key clinical features include abnormalities of the teeth (such as supernumerary or malpositioned teeth), lobulated tongue or tongue hamartomas, cleft lip and/or palate, and digital anomalies including postaxial polydactyly and clinodactyly. Facial features may include a broad nasal root and other midface abnormalities
How is Orofaciodigital syndrome type 3 inherited?
Orofaciodigital syndrome type 3 follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Orofaciodigital syndrome type 3 typically begin?
Typical onset of Orofaciodigital syndrome type 3 is neonatal. Age of onset can vary across affected individuals.